In lipodystrophy (LD) adipose tissue function to store lipids is impaired, leading to metabolic syndrome, similar to that found in obesity. Emerging evidence links dysmetabolism with disorders of the immune system. Our aim is to investigate whether T-cell populations with regulatory function and monocyte-derived macrophages (MDMs) are affected by LD and obesity. SUBJECTS/METHODS: Blood was collected from 16 LD, 16 obese (OB, BMI430 kg m − 2 ) and 16 healthy normal-weight women (CNT). Physical parameters, plasma lipid profile, glucose, HbA1c, leptin levels were determined. Flow cytometry was employed to assess the number of circulating CD4 + /CD25 hi regulatory T cells (Tregs) and invariant natural killer T (iNKT) cells. Characterization of MDMs included: 1. morphological/oil-Red-O staining analyses to define two morphotypes: lipid laden (LL) and spindle-like (sp) MDM; 2. gene expression studies; 3. use of conditioned medium from MDMs (MDMs CM) on human SGBS cells. RESULTS: As compared to CNT, LD and, to a lesser extent, obesity were associated with reduced Tregs and iNKTs (P o 0.001 and P o 0.01 for LD and OB, respectively), higher number of LL-MDMs (P o 0.001 and P o 0.01 for LD and OB, respectively), lower number of sp-MDMs (P o 0.001 for both LD and OB), which correlated with increased paracrine stimulation of lipid accumulation in cells (Po 0.001 and P o0.01 for LD and OB, respectively). LD MDMs showed decreased and increased expression for antiinflammatory (IL10 and CD163) and pro-inflammatory (CD68 and CCL20) marker genes, respectively. Analysis of correlation indicated that Tregs are directly related with HDL (P o 0.01) and inversely related with LL-MDM (P o 0.001) and that LL-MDM are directly related with triglycerides (P o 0.01) and oxidized LDL (P o 0.01). CONCLUSIONS: LD and obesity are associated with changes in the immune system: a significant reduction in the number of T cells with regulatory function and a shift of MDM towards lipid accumulation. Lipid profile of the patients correlates with these changes.
INTRODUCTION
Lipodystrophy (LD) syndrome is a group of rare, heterogeneous disorders characterized by selective loss of white adipose tissue, which varies from partial to generalized and occurs as a result of genetic defects or acquired conditions. 1 In some forms of LD an association with autoimmunity has been postulated. 2 Independently of the aetiology, LD patients are usually diagnosed with metabolic-related disorders, including insulin resistance, dyslipidemia, non-alcoholic fatty liver disease and reminiscent of a dysmetabolic condition typical of obesity. The severity of the metabolic phenotype is approximately proportional to the degree of WAT loss and tends to be worse in generalized LD 1 Fat depletion in LD mainly affects the subcutaneous WAT (SAT), the healthy type of fat where excess lipids should be ideally stored. These data explain why in LD reduced or absent expandability of SAT greatly impairs the capacity of the organism to properly store TGs and leads to ectopic lipid storage, resulting in insulin resistance and severe metabolic alterations. 3 The bidirectional interaction between immune system (IS) and whole-body metabolism is a widely recognized concept supported by: (1) the impaired immune defence and the higher susceptibility to infections found in obese individuals; 4 (2) the relationship between immune function and nutritional status, with undernourishment and overfeeding both altering the function of T cells; 5 (3) the notion that the altered metabolic state of obesity, being characterized by elevated circulating levels of glucose, cholesterol and fatty acids, can result in reactive oxygen species generation and lipid peroxidation, with a consequent inflammatory phenotype of immune cells. 6 Despite this evidence, the impact of systemic immune dysfunction occurring in conditions of excessive or depleted fat mass is far to be completely understood.
Compelling evidence supports the existence of a population of CD4 + T cells able to suppress immune over-reactivity in various inflammatory conditions, including autoimmune diseases and cancer. 7 These cells are characterized by a constitutive and strong expression of the IL2 receptor alpha chain (CD25), which defines a subset of naturally arising CD4 regulatory cells, the CD4 + /CD25 high (CD4 + /CD25 hi ) T cells (for the purpose of this study defined as Tregs), first identified in animals as a population of suppressor T cells that maintain peripheral immune tolerance by inhibiting the activation and expansion of self-reactive T cells. 8 Another population of immune cells, invariant natural killer T (iNKT) cells, play a role in various pathological conditions, including microbial infection, autoimmune disease, cancer and metabolic syndrome. 9 In both mice and humans, circulating iNKT cell number negatively correlate with weight gain. 10 Interestingly, it was shown that iNKTs accumulation in adipose tissue promotes an anti-inflammatory phenotype in macrophages and stimulates proliferation and function of Tregs. 11 Thus, iNKT cells are thought to play a protective role against obesity-induced inflammation and reduced glucose tolerance. 10 Monocyte-derived macrophages (MDMs) are commonly accepted as a good in vitro model recapitulating macrophages that infiltrate tissues. MDMs can be polarized in vitro into proinflammatory M1 or anti-inflammatory M2 phenotypes, by exposure of monocytes to cytokine/chemokine cocktails, or colony stimulating factors (CSFs). These two phenotypes represent the extremes of a continuous spectrum of macrophage subtypes, which can be found in human and animal tissues, indicating the high degree of phenotypic plasticity of these cells. 12, 13 Infiltration of WAT by macrophages is an example of this plasticity: in lean individuals M2 macrophages predominate, whereas in obese patients a shift towards the pro-inflammatory M1 subtype prevails.
14 Besides M1 and M2, another subtype of macrophages has been described, which constitute a prominent feature of inflammation in atherosclerotic plaques, the lipid laden macrophages (LL-MDMs), also known as foam cells. LL-MDMs develop by internalization of modified lipoproteins, in particular oxidized form of LDL (ox-LDL), which plays a critical role in foam cell formation both in vitro and in vivo. Foam cells are characterized by expression of multiple scavenger receptors and the presence of cytosolic lipid droplets. 15, 16 In addition, it was reported that foam cells can develop in vitro when MDMs are cultivated with autologous human serum, whereas rarely when monocytes are grown in fetal bovine serum. 17 The function of the IS in LD has been investigated only in the context of the effects of leptin replacement: Oral et al. 18 report that in basal conditions the number of B lymphocytes is reduced with respect to normal range values, whereas no differences were observed for various subsets of T cells. In the present study, we focused on the populations of immune cells known to be regulated by the metabolic state and on the phenotype of MDMs. As a second aim, we investigated whether these changes are due to fat depletion per se or due to dysmetabolic condition resembling those of obese subjects. To this end, a group of obese individuals, matched for sex and age with LD patients, was studied.
MATERIALS AND METHODS

Study population
The study group included 16 women diagnosed with different types of LD, including 6 patients with Dunnigan (DUN). All DUN patients were heterozygous for already reported 19, 20 nucleotide missense mutation in the LMNA gene (Supplementary Table 2 
Isolation and culture of MDMs
Total peripheral blood mononuclear cells were isolated by density gradient centrifugation using Ficoll-Histopaque 1.077 (Sigma Diagnostics, St Louis, MO, USA) according to the manufacturer's instructions. Recovered cells were washed with PBS and suspended in RPMI-1640 medium supplemented with 2% heat inactivated fetal bovine serum (HI-FBS). To eliminate lymphocyte contamination and mature circulating endothelial cells, an initial pre-plating step was performed by plating 1.5 × 10 6 cells per well in six wells of 24-well plates. After 1 h, non-adherent cells were removed and the plates were washed four times with RPMI-1640+2% HI-FBS. Adherent cells were grown in 1 ml of RPMI-1640 supplemented with 10% fresh autologous human serum (Supplementary Method 1). Growth medium was replaced every 3 days, and morphology of the MDMs evaluated after 7 days using a light microscope (LeicaDMIL, Wetzlar, Germany). MDMconditioned media (MDM-CM) were collected, centrifuged at 700 g for 15 min at 4°C to remove cells and debris and stored at − 80°C.
Oil-Red-O staining
Cells were fixed with 10% formaldehyde, stained for 10' at RT in freshly diluted Oil-Red-O (ORO) solution (6:4 parts of 0.5% ORO stock in isopropanol and double-distilled water) and washed five times (see Supplementary Method 3 for details).
Quantitative real-time PCR Total RNA was isolated from the MDMs cultured for 7 days, using combined TRIzol reagent (Life Technologies, Carlsbad, CA, USA) and Rneasy kit (Qiagen, Hilden, Germany) method according to manufacturer's instructions (see Supplementary Method 4 for details). cDNA was synthesized from 1 μg of total RNA using iScript Reverse Transcription Supermix for RT-qPCR (Bio-Rad, Pleasanton, CA, USA). Quantitative realtime PCR (RT-PCR) was performed using iTaq Universal Probes Supermix (Bio-Rad) with CFX96TM Real-Time System (Bio-Rad) instrument, and the relative mRNA expression for Tumour necrosis factor α (TNFα), CD68, Monocyte Chemoattractant Protein 1 (MCP1), Interleukin 1b (IL1b), C-C motif ligand 20 (CCL20), Interleukin 10 (IL10), CD206 and CD163 (Applied Biosystem, Foster City, CA, USA) genes was calculated using ΔΔ-Ct method. GAPDH gene expression was used for normalization of gene expression.
Effect of MDM-CM on Simpson-Golabi-Behmel syndrome cells proliferation and lipid accumulation
Simpson-Golabi-Behmel syndrome (SGBS) fibroblasts were grown as previously described 24 and seeded at a concentration of 2 × 10 3 cells per 
Statistics
Statistical power analysis using G*Power 3.1 (Heinrich-HeineUniversität Düsseldorf, Germany) showed that a total sample size of 45 patients enabled an 80% power to detect differences in the distribution of regulatory T cells between CNT, LD and OB patients at a significance level of 0.05 while assuming a large effect size (f = 0.5). Parametric tests were used when data were normally distributed and variances were not statistically different. Non-parametric tests were used in all the other cases as appropriate and are indicated in figure legends.
Non-parametric correlation analysis (Spearman) was performed considering the three groups as a single population. Statistical analysis was performed using GraphPad Prism 5 software (GraphPad Software, Inc., La Jolla, CA, USA). Data in bar graphs are expressed as mean ± s.e.m. P o0.05 was considered statistically significant.
RESULTS
Circulating T cells with regulatory function and MDMs morphological phenotype are modified in patients with DUN syndrome To determine whether LD is associated with changes in immune parameters, we first considered 6 female patients with DUN syndrome, the most common monogenic form of partial LD 25 and 16 healthy women (CNT). As assessed by flow cytometry, the percentage of circulating Tregs (CD4 + /CD25 hi ) and iNKTs (CD3 + /iNKT + ) in peripheral blood was significantly lower in the DUN as compared with the CNT group (Figures 1a and b) .
We then focused on the morphological phenotype of MDMs. After 7 days of cell culture in the presence of autologous serum, MDMs from DUN showed a distinct morphology compared with MDMs from healthy controls. Indeed, cells from CNT were markedly heterogeneous in size and shape, and included a significant number of spindle-like MDMs (Sp-MDMs), while cells from DUN were far more homogeneous, being mainly composed of large round lipid laden macrophages (see Supplementary Method 3 for details) (Figure 1c Table 2 ). To disentangle the effect of fat depletion from that of altered metabolism, we also recruited an agematched group of obese women (OB). The clinical characteristics of all patients and controls are presented in Tables 1 and 2 , in which DUN and non-DUN LD patients were combined. Clinical data show an altered glucose disposal for LD and dyslipidemia for both OB and LD. OB patients display a higher inflammation burden with respect to the other two groups. Although there were no significant differences in total LDL levels between the groups, the circulating levels of ox-LDL, previously reported to be higher in patients with HIV-related LD, 26 were increased in both LD and OB patients as compared to CNT (Table 1) .
Similar to what found in DUN patients considered separately, the number of Tregs and iNKTs was significantly reduced in LD patients as compared with CNT (Figures 2a and b) . OB patients showed an intermediate condition with a significant decrease as compared to CNT (Figures 2a and b) . Interestingly, number of Tregs was significantly associated to HDL levels ( Figure 2c ) when subjects were considered as a single population. The results of MDMs analysis were similar to those found in DUN patients. Indeed, the number of LL-MDMs was significantly greater, while Sp-MDMs were depleted in LD patients, as compared with controls ( Figure 3a) . MDMs from OB subjects showed numbers of LL-MDMs and Sp-MDMs similar to those observed in LD, even if the difference with controls was slightly less pronounced. Differences in the IS parameters mentioned in this paragraph remained statistically significant when diabetic patients (OB and LD) were removed from the analysis (Supplementary Figure 1) .
To investigate deeper in MDM function, we evaluated expression of the M1, M2 phenotypes in the three groups using gene expression by quantitative RT-PCR. M1 markers included TNFα, CD68, MCP1, IL1b and CCL20 while the M2 markers were IL10, CD206 and CD163. 27, 28 We could observe an increased expression for the M1 markers CD68, CCL20 and MCP1 in the LD group with significant and borderline significant differences for CD68 and CCL20, respectively (Figure 3b ). M2 markers tended to be lower in the LD group with IL10 and CD163 displaying statistically significant differences (Figure 3b) .
Next, we investigated whether the number of T cells with regulatory function and the MDM morphotype were interrelated. Indeed, the number of Sp-MDMs was positively related to the (Figure 3c ). We then asked whether morphology and lipid content of MDMs were associated with the clinical characteristics of patients. We observed that the number of Sp-MDMs was negatively related to TG and ox-LDL plasma levels, and was positively related to HDL plasma levels (Figure 4a ). On the other hand, LL-MDMs were positively related with TG and ox-LDL levels and were negatively related with HDL (Figure 4b) .
Taken together these data indicate that in LD and in obesity, Tregs and iNKTs are less represented with respect to healthy controls, this being associated with a higher number of LL-MDMs and a reduced number of Sp-MDMs. Interestingly, these changes are significantly associated with the lipid profile of the subjects.
Cross-talk between MDMs and SGBS cells
We next wanted to investigate whether the changes observed in MDMs from LD and OB corresponded to differences in their function. To this purpose, we examined the effect of conditioned medium (MDM-CM) from the cells of CNT, LD and OB on primary stromal fibroblasts isolated from WAT of a subject with SGBS cells. We observed that MDM-CM from CNT displayed a greater capacity to induce proliferation of SGBS cells as compared with standard culture conditions in DMEM medium (Figure 5a ). However, this growth-inducing effect was not reproduced by MDM-CM from LD that had a significantly weaker proliferating effect as compared to MDM-CM from CNT. The MDM-CM of cells from OB had a growth promoting effect that was intermediate between that of cells from LD and CNT (Figure 5a) .
Lipid droplets accumulation was also observed inside the MDM-CM-treated SGBS cells. ORO allowed quantifying this phenomenon: MDM-CM from LD induced a significantly greater lipid accumulation in SGBS cells as compared with MDM-CM from CNT or OB, the latter exhibiting an intermediate phenotype (Figures 5b  and c) . Similar differences in lipid accumulation were obtained when diabetic patients (OB and LD) were removed from the analysis (Supplementary Figure 2) . To rule out the possibility that lipid accumulation was induced by the presence of autologous human serum in MDM-CM (see Materials and Methods), SGBS cells were incubated for 96 h with DMEM containing 10% of human serum from CNT or LD patients. ORO staining analysis confirmed that there was no significant difference in the lipid accumulation induced by the human serum between LD and CNT (Supplementary Figure 3) . Regression analysis revealed that lipid accumulation by SGBS cells was positively related with plasma levels of TG and ox-LDL and negatively related with HDL (Figure 5d ).
These data indicate that MDMs from LD patients inhibit cell proliferation and induce lipid accumulation in a different cell type.
DISCUSSION
A comprehensive understanding of how fat depletion impacts various functions of the organism is yet to be reached. Because the IS is closely related to metabolism, the new term immunometabolism was created. 29 In the present study, we investigated the effect of fat depletion on the IS by analyzing T cells with regulatory function and the phenotype of MDMs. We first studied a homogeneous group of LD patients with DUN syndrome, who, when compared to controls revealed lower circulating levels of Tregs and iNKTs and striking change in the population of MDMs, characterized with higher appearance of lipid laden macrophages and depletion of spindle-like cells. Similar results were obtained when we extended the investigation to a larger and more heterogeneous group of LD patients and to OB patients.
Data from animal models showed that Tregs play a crucial role in the suppression of the autoimmune response as indicated by their inhibitory function in the synovial compartment of patients with rheumatoid arthritis and their capacity to inhibit the proliferation of autologous CD4/CD25 -effector T cells in vitro.
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Decreased levels of Tregs and iNKTs were reported in several diseases, some with a clear autoimmune aetiology including systemic lupus erythematosus 31 and primary Sjögren's syndrome. 32, 33 A significantly reduced number of iNKTs was found in patients with autoimmune T1D diabetes. 34 It is then somehow expected to find important alterations of these parameters in forms of acquired LD with an autoimmune aetiology. 35, 36 Less obvious is this finding in genetically determined forms as herein found. In this regard, we could speculate that the altered numbers of T cells with regulatory function might not only be a consequence, but also a determinant of LD by triggering a specific action against adipocytes. Indeed, even in genetically determined partial LD, fat depletion is not apparent at birth and progressively appears later in life. 37 OB also showed a reduction of T cells with regulatory function; the depletion was mild for Tregs, and more pronounced for iNKTs, this being consistent with what previously documented in animal models and human subjects. 10, 29, 38 Interestingly, a recovery to normal levels of iNKT is obtained following weight loss in humans and mice. 10 Far less obvious is the. respectively, higher and lower representation of lipid laden (LL-MDMs) and spindle-like cells (Sp-MDMs) among the MDMs from LD and OB. LL-MDMs have been associated with M1 pro-inflammatory phenotype while SpMDMs with M2 anti-inflammatory macrophages. 39 To further understand the reasons for the different representation of MDM morphotypes in LD, CNT and OB, we can analyse how this relates to other findings of the present study. First, the numbers of Sp-MDMs and LL-MDMs correlated with those of Tregs and iNKTs in a positive and negative way, respectively. Even if no cause-effect relationship can be established in the present study, this result discloses previously uncovered links between these immune cells and may indicate that a common determinant is affecting both MDMs and T cells with regulatory function. Second, correlation analysis between clinical parameters and MDM phenotype gave some indications, albeit indirect, about the 15 The correlation between ox-LDL and LL-MDMs is not surprising, 40 given that ox-LDL uptake by macrophages gives rise to foam cells, critical determinants in the formation of atherosclerotic plaques.
Third, higher representation of LL-MDMs in LD patients was associated with a higher expression of the pro-inflammatory M1 markers CD68 and CCL20, and a lower expression of the antiinflammatory markers IL10 and CD163. The induction of the latters characterizes M2 macrophage polarization 27 and decrease in IL10 levels are associated with multiple inflammatory conditions and ageing. 41 Consistent with what herein found it was shown that high ox-LDL is associated to increased CD68 expression, 42 while IL10 was shown to inhibit ox-LDL-induced lipid uptake in macrophages. 43 High ox-LDL is a clinically relevant predictor of metabolic syndrome. 44 Our findings, in line with the increased ox-LDL found in HIV-related LD, 26 point to a condition in which the high levels of this circulating lipoprotein and the expression profile of macrophages concur to the formation of foam cells in both obesity and LD.
Finally, the morphotype distribution corresponded to a different MDM paracrine action as cells cultivated with MDM-conditioned medium from LD or OB exhibited reduced proliferation rate and increased lipid uptake. Importantly, there was a positive correlation between circulating TGs and lipid accumulation induced by MDM-CM, the opposite was true for HDL. These data suggest two, not necessarily alternative, hypotheses. The first, more speculative, is that certain types of macrophages play a role in the ectopic fat deposition that characterizes both LD and morbid obesity. The second, more obvious, is that lipid profile is not only a determinant of MDM phenotype, but also of their function.
Lipids emerge from this study as important determinants of the immune response, both systemic and within tissues, as herein shown in vitro by MDMs properties or function. Indeed, patients with LD or OB show similar trends for each aspect of the immune response being considered, but the former often presents with a more pronounced difference, as compared to healthy controls. Of note, high inflammatory markers characterize the obese patients only, supporting the notion that the low-grade chronic inflammation, observed in the presence of excess and inflamed WAT, 45 do not significantly relate with immune function (at least for the parameters herein analysed), whereas metabolic alterations importantly do.
In conclusion, we established that LD and obesity are associated with changes in the immune parameters including: depleted number of T cells with regulatory function (Tregs and iNKTs) and overrepresentation of lipid laden monocyte-derived macrophages, associated with enhanced paracrine capacity to induce lipid accumulation. These features correlate with the lipid profile of the patient.
Our findings define a new hallmark characterizing the systemic condition of LD and obesity, add a new evidence to the concept that excess or depletion of adipose tissue may result in similar dysfunctions, and finally further strengthen the relationship between metabolism and the immune system.
